The FDA ruled that this is a Class I recall due to the significant risks for patients. Customers are not required to return the devices, however. Inari Medical has provided updated warnings and recommendations that should be followed. The FDA ruled that this is a Class I recall due to the significant risks for patients. Customers are not required to return the devices, however. Inari Medical has provided updated warnings and recommendations that should be followed. | | |
|
Researchers combined data from three well-known clinical trials—NOTION, Evolut Low Risk and PARTNER 3—and evaluated thousands of low-risk patients who presented with severe aortic stenosis. Researchers combined data from three well-known clinical trials—NOTION, Evolut Low Risk and PARTNER 3—and evaluated thousands of low-risk patients who presented with severe aortic stenosis. | | |
|
The Florida-based healthcare company, already a leading name in cardiac data management, said the acquisition will help its technology reach more heart teams than ever before. The Florida-based healthcare company, already a leading name in cardiac data management, said the acquisition will help its technology reach more heart teams than ever before. | | |
|
CMS wants feedback after proposing a significant update to CCTA reimbursement payments. The American College of Cardiology, a longtime champion for improved cardiac CT payments, is now helping its members make their voices heard. CMS wants feedback after proposing a significant update to CCTA reimbursement payments. The American College of Cardiology, a longtime champion for improved cardiac CT payments, is now helping its members make their voices heard. | | |
|
The Cardiovascular Research Foundation has announced 10 late-breaking clinical trials and 15 late-breaking clinical science sessions for TCT 2024 in Washington, DC. Topics will include TAVR and other structural heart procedures, artificial intelligence and much more. The Cardiovascular Research Foundation has announced 10 late-breaking clinical trials and 15 late-breaking clinical science sessions for TCT 2024 in Washington, DC. Topics will include TAVR and other structural heart procedures, artificial intelligence and much more. | | |
|
Mayo Clinic specialists have developed a new way to identify risks of cardiovascular disease, diabetes and other adverse outcomes. Mayo Clinic specialists have developed a new way to identify risks of cardiovascular disease, diabetes and other adverse outcomes. | | |
|
The new AUC document was designed to help care teams know when and how to perform imaging-based cardiovascular evaluations on patients undergoing nonemergent, noncardiac surgery. The new AUC document was designed to help care teams know when and how to perform imaging-based cardiovascular evaluations on patients undergoing nonemergent, noncardiac surgery. | | |
|
The nine-minute flight was a complete success. Prior Blue Origin space tourism missions have included everyone from Bezos himself to Star Trek actor William Shatner. The nine-minute flight was a complete success. Prior Blue Origin space tourism missions have included everyone from Bezos himself to Star Trek actor William Shatner. | | |
|
The new interventional device from Renata Medical is designed to expand as young patients age, providing long-term relief. The new interventional device from Renata Medical is designed to expand as young patients age, providing long-term relief. | | |
|
Brittany Nicole Weber, MD, PhD, detailed new research into the benefits of screening for cardiovascular disease in CT scans not specifically ordered for that purpose. The rise of AI has helped make opportunistic screening a huge trend in both cardiology and radiology. Brittany Nicole Weber, MD, PhD, detailed new research into the benefits of screening for cardiovascular disease in CT scans not specifically ordered for that purpose. The rise of AI has helped make opportunistic screening a huge trend in both cardiology and radiology. | | |
|
Heart issues are the No. 1 cause of death for liver transplant patients. Screening patients for signs of CAD is one way care teams can help keep such complications to a minimum. Heart issues are the No. 1 cause of death for liver transplant patients. Screening patients for signs of CAD is one way care teams can help keep such complications to a minimum. | | |
|
Pedro Martinez Clark, MD, FSCAI, interventional cardiologist, medical director of Amavita Heart and Vascular Health in Miami, set up community outreach efforts to screen patients in low-income neighborhoods.
Pedro Martinez Clark, MD, FSCAI, interventional cardiologist, medical director of Amavita Heart and Vascular Health in Miami, set up community outreach efforts to screen patients in low-income neighborhoods.
| | |
|
